Systematic review reveals vitamin D supplementation significantly reduces depression in postpartum women and young adults, suggesting potential benefits over placebo.
Background We conducted a systematic review and meta-analysis to assess the effect of vitamin D supplementation on depression among adolescents and young adults compared with placebo and baseline. Methods We searched databases and reference lists from inception to May 2024 for English-language studies, including cohort studies, case studies, and randomized clinical trials. Study quality was assessed using the Cochrane RoB2 tool and the Newcastle-Ottawa Scale. Random-effects meta-analyses estimated the standardized mean difference (SMD) in depression scores (primary outcome) and anxiety scores (secondary outcome). Heterogeneity was assessed using the I² statistic. Results Fifteen studies (2010–2024) from 7,638 citations met inclusion criteria. The mean sample size was 5,271 (range: 38–74,840). Meta-analysis of nine studies showed that vitamin D supplementation significantly reduced depression scores versus placebo (SMD: −0.43; 95%CI: −0.75 to −0.12; p=0.007; I²=78%). Of six studies not included in the meta-analysis, five reported significant associations between supplementation and lower depression. Subgroup effects were observed for postpartum women (SMD: −0.55; 95%CI: −1.04 to −0.06; p<0.05; I²=83%) and young adults (SMD: −1.38; 95%CI: −1.65 to −1.10; p<0.001; I²=76%). Meta-analysis of four studies found no significant association with anxiety (SMD: −0.31; 95%CI: −0.75 to 0.12; p=0.16; I²=77%). Limitations Variability in study sample sizes may affect interpretation and generalizability. Conclusions Vitamin D supplementation was associated with lower depression scores, with effects varying by subgroup.
No takes yet. Share an insight, caveat, or question.
Nano et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: